Novo Nordisk BioInnovation meets TUM Smart Drug Design
28.08.2024
TUM had the privilege of hosting the board of the Novo Nordisk BioInnovation Institute as well as the Bavarian State Minister for Health and Prevention, Judith Gerlach, for an exciting exchange of ideas and innovations. BII CEO Jens Nielsen, along with the Novo Nordisk Foundation leadership, explored the Munich TUM Venture Labs and engaged with key research groups, including many members of the TUM Center for Smart Drug Design. The event featured presentations from leading TUM start-ups and institutes, paving the way for future collaboration between Denmark and Bavaria.